Frontlight ResearchEarly access
CompletedNo phase
Safety and Performance of the Journey™ II UNI Unicompartmental Knee System
Key facts
- Who runs it
- Smith & Nephew, Inc.
- Where
- Chicago and Rockford, United StatesSee the 2 sitesAlso in 2 other countries, 4 sites
- Trial code
- Status
- Completed
- People taking part
- 154 people enrolled
- Started
- 10 Aug 2018
- Ended
- 19 May 2025
- Type of study
- Observational
- Treatments tested
- Journey™ II UNI Unicompartmental Knee System
- Record updated
- 27 February 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (2)Hide the full registry criteria
Who can take part
- Subjects must meet all of the following criteria for inclusion in the study; Unicompartmental, NIDJD, including OA, traumatic arthritis, or avascular necrosis; Eighteen (18) years of age or older at the time of surgery; Skeletally mature in the judgement of the PI; Has met an acceptable preoperative medical clearance and is free of (or acceptably managed) cardiac, pulmonary, hematological, infection, or other conditions that would pose an excessive operative risk; Willing and able to participate in required follow-up visits at the investigational site and to complete study procedures and questionnaires; Consented to participate in the study by signing the EC-approved ICF
Who cannot take part
- Subjects meeting any of the following criteria must be excluded from participation in the study; Correction of functional deformity; Revision procedures where other treatments or devices have failed; Treatment of fractures that are unmanageable using other techniques; Inadequate bone stock to support the device which would make the procedure unjustifiable, including but not limited to severe osteopenia/osteoporosis or family history of severe osteoporosis/osteopenia; Body Mass Index (BMI) > 40; Collateral ligament insufficiency; Active infection, treated or untreated, systemic or at the site of the planned surgery or previous intra-articular infections; Incomplete or deficient soft tissue surrounding the knee; Conditions that may interfere with the UKA survival or outcome, including but not limited to Paget's disease, Charcot disease, vascular insufficiency, muscular atrophy, uncontrolled diabetes, renal insufficiency or neuromuscular disease; Diagnosis of an immunosuppressive disorder; Known allergy to study device or one or more of its components; Pregnant or planning to become pregnant during the course of the study; Subject, in the opinion of the PI, has an emotional or neurological condition that would pre-empt their ability or willingness to participate in the study including mental illness, mental retardation
Where in United States
Also in 2 other countries, 4 sites
- Rush University Medical CenterChicago, United States
- OrthoIllinois, LTDRockford, United States
About the trial
What the trial wants to find out
This clinical study will evaluate the early to midterm safety and performance of the JOURNEY™ II UNI UKS in patients with non-inflammatory degenerative joint disease of the knee requiring lateral or medial knee compartment replacement. Clinical, radiographic, health economic and safety outcomes will be evaluated.
Treatments tested
- Journey™ II UNI Unicompartmental Knee System
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Prospective, Multicenter Post-Market Clinical Follow-up Study to Evaluate the Safety and Performance of the Journey™ II UNI Unicompartmental Knee System
- Record updated
- 27 February 2026